Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anika Therapeutics (ANIK) Amortization - Goodwill (2020)

Anika Therapeutics (ANIK) has disclosed Amortization - Goodwill for 1 consecutive years, with $24.4 million as the latest value for Q4 2020.

  • On a quarterly basis, Amortization - Goodwill changed N/A to $24.4 million in Q4 2020 year-over-year; TTM through Sep 2021 was $24.4 million, a 34.56% increase, with the full-year FY2020 number at $42.5 million, changed N/A from a year prior.
  • Amortization - Goodwill was $24.4 million for Q4 2020 at Anika Therapeutics, up from $18.1 million in the prior quarter.
  • In the past five years, Amortization - Goodwill ranged from a high of $24.4 million in Q4 2020 to a low of $18.1 million in Q1 2020.